Leading the way, this is the only industry-dedicated forum placing donor testing, screening, retention and cell source selection in the main spotlight to drive scalable allogeneic manufacturing development and streamline both supply chain and process development.
Download this year's program to discover:
- A star studded 80% new speaker faculty & six brand new speaking companies
- Interactive, discussion-based sessions to facilitate your networking & tackle common challenges together
- Brand new sessions & data on new techniques for screening donors, including rapid assays, computational analytics, and more
*If you are having issues downloading the agenda,
get in touch here.
How to Overcome Your Top Challenges:
Struggling to Nail Characterization Testing?
Join ImmuneBridge as they highlight their use of computational tools to screen donors and identify top performers that drive precision and consistency in allogeneic therapies.
Uncertain About the Investment Landscape?
Join BroadOak Capital and Allogene Therapeutics in their interactive roundtable discussion to put your questions to the room and brainstorm solutions with the experts.
Looking to Understand More About Other Companies' Starting Material Use?
Join Luminary Therapeutics, Artiva Therapeutics, and Genentech as they share case studies on their methods and steps taken to manage inter- and intra-donor variability across a variety of starting material types.
For more expert insights on how to tackle your biggest challenges in donor selection and cell sourcing, explore the expert insights in this year's program.
Companies in the Program Include:
